Novartis Loses Fight With USPTO To Extend 19 Patents

Law360, New York (November 16, 2012, 1:44 PM EST) -- A Washington federal judge on Thursday nixed Novartis AG's bid to extend the life on 19 of its patents, ruling the drugmaker waited too long before challenging the U.S. Patent and Trademark Office's patent term adjustment calculations.

U.S. District Judge Ellen Segal Huvelle said Novartis isn't entitled to a recalculation on those patents because it waited more than 180 days before filing complaints challenging the USPTO's determinations. Judge Huvelle, however, granted Novartis' request to have the USPTO recalculate patent term adjustments for four other patents —...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

NOVARTIS AG et al v. KAPPOS


Case Number

1:10-cv-01138

Court

District Of Columbia

Nature of Suit

Patent

Judge

Ellen S. Huvelle

Date Filed

July 6, 2010

Law Firms

Companies

Government Agencies

Patents

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.